• Cynthia Bassett Hartwig

    Cynthia Bassett Hartwig is a prominent name in the world of biomedical research, currently serving as the Chief Financial Officer at Fluxion Biosciences. Headquartered in Oakland, California, Fluxion Biosciences is a leading player in predictive discovery, precision diagnostics, and biotechnology research, offering advanced solutions to automate complex cell-based and cell-free assays. Cynthia oversees and manages various financial functions for Fluxion Biosciences, including accounting, auditing, corporate finance, investor relations, and treasury. Additionally, she is responsible for driving the organization's business leadership, corporate strategy, and human resources.


    Cynthia's impressive range of responsibilities also includes ensuring compliance with federal, state, and local legal requirements, establishment, monitoring, and enforcing of internal controls, management of cash flow, ongoing streamlining of accounting processes and software integration, oversight of reporting for external and internal purposes, planning, direction, and coordination of operational functions, provision of strategic recommendations to the CEO, review of formal finance and IT-related procedures, strategic support of executive management teams, the study of legislation, and filing of legal documents.


    Before joining Fluxion Biosciences, Cynthia was a senior finance professional associate with Ultralox Interlocking Technology's manufacturing company. During her tenure, she was responsible for financial reporting, statement analysis, balance sheet reconciliation, and records maintenance. Ultralox Interlocking Technology is a premium aluminum railing systems manufacturer in Dakota County, Minnesota. It is known for its dedication to research and development, ensuring its products meet stringent building codes nationwide.


    Cynthia's finance expertise and strategic thinking skills are highly regarded in the industry, making her an invaluable asset to any organization she works for. Her contributions to Fluxion Biosciences have driven the company's growth and success.